These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1626953)
1. [Combined therapy with 5-FU and levamisole]. Mitomi T; Noto T Gan To Kagaku Ryoho; 1992 Jul; 19(7):970-4. PubMed ID: 1626953 [TBL] [Abstract][Full Text] [Related]
2. Levamisole with fluorouracil for colon cancer. Med Lett Drugs Ther; 1989 Oct; 31(802):89-90. PubMed ID: 2674639 [No Abstract] [Full Text] [Related]
4. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer. Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D; Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198 [TBL] [Abstract][Full Text] [Related]
5. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089. Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627 [TBL] [Abstract][Full Text] [Related]
6. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer. Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775 [TBL] [Abstract][Full Text] [Related]
10. [Effect of levamisole in postoperative adjuvant immunochemotherapy of stomach cancer--randomized controlled study of MMC-5-FU combination therapy with or without levamisole. 1]. Niimoto M; Hattori T; Itoh I; Tamada R; Inokuchi K; Orita K; Furue H; Ogawa N; Tsuji H; Furusawa M; Tomita M; Taguchi T; Kosaki G; Iwanaga T; Hioki K; Kondo T; Yura J; Hirano M; Miura K; Izuo M; Takemiya S Gan To Kagaku Ryoho; 1982 Dec; 9(12):2148-60. PubMed ID: 6820891 [TBL] [Abstract][Full Text] [Related]
12. Optimal duration of fluorouracil plus levamisole colon cancer surgical adjuvant therapy. O'Connell MJ; Kahn MJ; Erlichman C; Goldberg RM; Shepherd LE J Clin Oncol; 1996 Oct; 14(10):2887. PubMed ID: 8874353 [No Abstract] [Full Text] [Related]
13. [Adjuvant chemotherapy improves chances of survival in curative surgery of colon cancer, Dukes' stage C]. Porschen R; Stremmel W Z Gastroenterol; 1990 Jul; 28(7):375-6. PubMed ID: 2238769 [No Abstract] [Full Text] [Related]
14. Immunological alterations induced by adjuvant treatment of postoperative colon carcinoma Duke's B or C with levamisole in combination with 5-FU. De Brabander M; Vandebroek J; Wassenaar H; De Crée J; Baisier A; Demoen B; De Ridder R; Jagers E; Roels V; Vogels O Anticancer Res; 1995; 15(5B):2271-7. PubMed ID: 8572636 [TBL] [Abstract][Full Text] [Related]
15. A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancer. Schippinger W; Jagoditsch M; Sorré C; Gnant M; Steger G; Hausmaninger H; Mlineritsch B; Schaberl-Moser R; Mischinger HJ; Hofbauer F; Holzberger P; Mittlböck M; Jakesz R; Br J Cancer; 2005 May; 92(9):1655-62. PubMed ID: 15856042 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy of colorectal cancer. Kemeny N; Saltz L; Cohen A Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089 [TBL] [Abstract][Full Text] [Related]
17. [The current status of postoperative adjuvant chemotherapy for colorectal cancer]. Kodaira S Gan To Kagaku Ryoho; 1997 Aug; 24(10):1230-8. PubMed ID: 9279341 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant treatment of node-positive colon carcinoma with levamisole and 5-fluorouracil. Grem JL Oncology (Williston Park); 1991 Mar; 5(3):63-70, 73; discussion 73-4. PubMed ID: 1829947 [TBL] [Abstract][Full Text] [Related]
20. [Adjuvant therapy of colon cancer stage C MAC. Adverse effects and efficacy in the Department of Oncology, Soroka Medical Center in the years 1991-1994]. Ezekiel G; Walfisch S; Cohen Y Harefuah; 1999 Jun; 136(12):923-6, 1004, 1003. PubMed ID: 10955148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]